Clinical Trial Update: Lenalidomide in Kaposi Disease Associated With HIV Infection [Phase 2]

View source ↗

Summary

This update notes the termination of a Phase 2 trial evaluating lenalidomide for Kaposi sarcoma associated with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infection Associated Kaposi Disease | Phase 2 | Status: TERMINATED